Pulmonary Oedema is accumulation of fluid in lungs. It can be due to cardiogenic or non-cardiogenic causes. This presentation was a class presentation and discussed its management alongwith diagnosis.
Pleural effusion may be defined figuratively as the juice, oozing from the leaky lingerie of the lung. However the text book definition is the abnormal accumulation of fluid in the pleural space due to disturbances in the forces that keep the pleural fluid economy in equilibrium...
Pulmonary Oedema is accumulation of fluid in lungs. It can be due to cardiogenic or non-cardiogenic causes. This presentation was a class presentation and discussed its management alongwith diagnosis.
Pleural effusion may be defined figuratively as the juice, oozing from the leaky lingerie of the lung. However the text book definition is the abnormal accumulation of fluid in the pleural space due to disturbances in the forces that keep the pleural fluid economy in equilibrium...
Basic information on the Graphics displayed on the Ventilators. Prepared to educate about the graphics to train the professionals who work with Ventilators.
Basic information on the Graphics displayed on the Ventilators. Prepared to educate about the graphics to train the professionals who work with Ventilators.
Abnormal fluid accumulation in potential space in between parietal and visceral pleurae – there is imbalance between formation and absorption in response to injury, inflammation or both locally and systematically
Pleural effusion caused by malignancies has been described as malignant pleural effusion. Etiology,pathogenesis,diagnosis and management of malignant pleural effusion has been descibed in this powerpoint presentation.
Apparently a lengthy presentation actually very good for junior physicians as it covers all aspects of assessment, diagnosis and treatment of pleural effusion
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
2. DEFINITION
• Pleural effusion results from fluid accumulating in
the potential space between the visceral and
parietal pleura When there is an imbalance
between formation and absorption in various
disease states , in response to injury ,
inflammation, or both locally and systematically .
3. PLEURAL FLUID FORMATION
• Pleural fluid that normally enter the pleural space
originates in the capillaries in parietal pleura
•Pleural fluid absorbed by lymphatic vesseles in the
parietal pleura by means of stoma in the parietal
pleura
4. •Rate of formation equals the rate of absorption
which is about 0.01 – 0.02 ml/kg per hr.
• Lymphatics have the capacity to absorb 20 times
more than what is Produced
• Fluid can also enter the pleural cavity from
interstitial spaces of lung through visceral pleura
5. PATHOGENESIS OF PLEURAL EFFUSION
•Pleural fluid accumulates when the rate of pleural
fluid formation exceeds the rate of pleural fluid
reabsorption
• Normally 0.01ml/kg /hr of fluid constantly enters
the pleural space from the capillaries in the parietal
pleura
•Almost all the fluid removed by the lymphatic in the
parietal pleura which have the capacity to remove
8. SEPARATION OF TRANSDUATIVE FROM
EXUDATIVE EFFUSION (LIGHT S CRITERIA)
•Pleural fluid protein-to-serum protein ratio more
than 0.5
•Pleural fluid LDH-to-serum LDH ratio more than 0.6
•Pleural fluid LDH level greater than two third the
upper limit of normal serum level
9. SERUM-EFFUSION ALBUMIN GRADIENT (SAG)
• In general Light’s criteria occasionally misidentify a
transudative effusion as an exudative effusion as in
cardiac failure with diuretic therapy
• Clinically if a patient should have a transudative
effusion, but meets Light’s criteria for an exudative
effusion, measure serum - pleural fluid albumin
gradient,or measure the serum-pleural protein
gradient
10. Serum- effusion albumin gradient of more
than 1.2 g/dl transudative
Serum-effusion protein gradient more
than 3.1g/dl transudative
An alternative approach to measure NT
pro BNP level(>1500pg/ml)
11. OTHER TESTS
• SPECIFIC GRAVITY-used in past to separate transudative from
exudative. A specific gravity of 1.015 corresponds to protien
contents of 3 g /dl, and this value was used to separate from
exudative from transudative
• NT PRO BNP-the level of NT pro BNP in the pleural fluid are used
to establish the diagnosis of CHF(>1500pg/ml).
12. GLUCOSE MEASURMENT-low pleural
glucose level (<60mg/dl)indicates-
parapneumonic effusion, malignant
disease, rheumatoid disease,
tuberculus pleuritis. presence of low
glucose level is poor prognostic sign in
parapneumonic effusion
13. AMYLASE DETERMINATION-pleural fluid
amylase level above upper normal limit
(200iu/ml)for serum indicates the patient
has one of three problem1
1 pancreatic disease
2 malignant tumor
3 esophageal rupture
Amylase in
malignant pleural effusion and esophageal
rupture is of salivary type.
14. LDH MEASUREMENT
LDH is reliable indicator of the degree of pleural
inflammation, higher the LDH ,more inflamed the
pleural surface
most of the patient who meet the criteria of
exudative pleural effusion with LDH but not with
protein level have either parapneumonic effusion
or malignant pleural disease
15. LDH isoenzyme determination in only one
situation when there is bloody pleural effusion in
a patient who is clinically thought to have
transudative pleural effusion. if LDH is in
exudative range, and the protein in transudative
range ,the demonstration the most of LDH is
LDH1 indicates that the increase in the LDH is due
to blood
16. PH -If the pleural fluid pH is less than 7.2 it
means that the patient has 1 of 10 conditions
1 .Complicated parapneumonic effusion
2. Esophageal rupture
3 . Rheumatoid pleuritis
4. Tuberculous pleuritis
5. Malignant pleural disease
6. Hemothorax
7. Systemic acidosis
8. Paragonimiasis
9 . Lupus pleuritis
10. Urinothorax
17. In general pleural fluid with low pH also
have a low glucose and high LDH level. if
the laboratory report a low pH with normal
glucose and low LDH level ,the pH
measurement probably a laboratory error
18. Total and Differential Cell Counts
Predominance of neutrophils in the fluid
>50% indicates that an acute process is
affecting the pleura.
IL8 is primary chemotaxins for neutrophil in
the pleural space.
Common causes include
• parapneumonic effusions (81 percent),
• effusions secondary to pulmonary
embolus (80 percent), and
• those secondary to pancreatitis(80
percent).
19. Mononuclear cells like small
lymphocytes >50% indicates a chronic
process.
• cancer or tuberculous pleuritis,
• effusions after coronary-artery bypass
surgery,
20. Pleural-fluid eosinophilia >10%
• IL5(CD4 CELLS) and eotaxin 3.
• caused in about two thirds of cases by
blood or air in the pleural space.
• uncommon in cancer or tuberculosis,
unless the patient has undergone repeated
thoracentesis
• Other causes reactions to drugs
(dantrolene, bromocriptine, or
nitrofurantoin), exposure to asbestos,
paragonimiasis, and the Churg–Strauss
syndrome
21. MARKERS OF TUBERCULOSIS
• ADA MEASUREMENT-ADA is enzyme that catalyze the
conversion of adenosine to inosine. cutoff level is 40u/l.
• Two main disease that cause an elevated ADA in addition
to tuberculosis are rheumatoid pleuritis and empyema.
• If the diagnostic criteria for tuberculous pleuritis patient
also include a pleural fluid lymphocyte to neutrophil ratio
greater than 0.75 the specificity of the test is increased.
22. • ADA has 2 isoenzymes ADA1 and
ADA2.ADA1 is produced by lymphocyte,
neutrophil , monocyte and macrophage.in
contrast ADA 2 exist only in monocyte and
macrophages. the increase in ADA activity in
tuberculous pleuritis is mainly due to ADA2
.(origin of pleural fluid ADA is probably
pleural tissue).ADA1 to ADA2 ratio of less
than 0.42 increased the accuracy.
23. Markers of Tuberculosis
INTERFERON-GAMMA
• Produced by cd4 lymphocyte
• levels above 140pg/ml/3.7 U/ml are very
suggestive of TB
• Elevated whether or not the patient is
immunosuppressed
• Is more expensive than ADA
• Sensitivity and specificity for interferon-
gamma is 96%
24. C REACTIVE PROTIEN
• Patient with tuberculous pleuritis tend to
have higher pleural fluid level of C reactive
protein than do patient with other
lymphocytic pleural effusion. Level >50
mg/dl high specificity for tuberculosis. but it
doesn’t appear to be as accurate as ADA
level
25. • Lysozyme-the level of lysozyme in pleural
fluid tend to be higher in pleura fluid from
patient with tuberculous pleuritis than in
other types of exudate.
• Procalcitonin-higher mean level with
empyema followed by parapneumonic
effusion and then tuberculous pleurisy and
malignant pleural effusion
26. • If eosinophils are found in pleural fluid in
significant number(>10 %)one can virtually
exclude the diagnosis of tuberculous
pleuritis unless the patient has
pneumothorax or had a previous
thoracentesis
• Pleural fluid from patient with TB rarely
contains more than 5% mesothelial cells.it
has been suggested that hiv infected with
TB have significant number of mesothelial
cells.
27. PCR FOR DIAGNOSIS OF TUBERCULOUS
PLEURITIS
• With PCR one can identify the presence of
DNA from M. tuberculosis in the pleural
fluid
• PCR was not superior to an ADA level >45
• In general PCR in pleural fluid has been
less sensitive than PCR of other material
• Sensitivity and specificity of PCR for
diagnosis of tuberculus pleuritis is 81% and
100% respectively
28. Pleural biopsy in tuberculous pleuritis
• demonstration of granuloma in the parietal
pleura suggests tuberculous pleuritis; caseous
necrosis and AFB need not be demonstrated
• More than 95 per of patient with granulomatous
pleuritis have TB
• ADA which are at least as sensitive in
diagnosing tuberculous pleuritis as needle biopsy
of the pleura, resulted in decrease use of the
needle biopsy of pleura
• Indication of needle biopsy of pleura
1. Tuberculous pleuritis
2. malignancy
29. Smears and Cultures
• for nonimmunosuppressd patients routine smears
of the pleural fluid for mycobacteria are not indicated
because they are usually negative, unless the patient
has tuberculous empyema
• Pleural fluid from patients with undiagnosed
exudative pleural effusion should be cultured for
bacteria, mycobacteria and fungi.
30. • Fluid should be inoculated directly into blood
culture media at bedside because the number
positive culture will increase with this methods
• For mycobacteria culture use of BACTEC system
with bedside inoculation provides higher yields and
faster result.
• The sensitivities of pleural fluid culture and AFB
smear were 42% and 1%, respectively
31. RADIOGRAPHIC EXAMINATION
• the fluid first gravitates at the base of hemithorax and come to
rest between inferior surface of the lung and diaphragm,
particularly posteriorly where the pleural sinus is most posteriorly
• Subpulmonic or infrapulmonary effusion
1. At times for unknown reason substantial amount of pleural fluid
(>1000ml)can be present may remain in an infrapulmonary
location without spilling into costophrenic sulci or extending up
the chest wall. such pleural fluid accumulation are called
subpulmonic or infrapulmonic effusion
32. 2. presence of one or more of these characteristics
serve as an indication of decubitus examination
a)apparent elevation of one or both diaphragm
b)apex of apparent diaphragm is more lateral than
usual c)slope of apparent diaphragm is more sharply
towards the costophrenic angle
d)normally the top of the left diaphragm on the PA
view is less than 2 cm above stomach air bubble .a
separation greater than 2 cm suggests subpulmonic
effusion
e)lower lobe vessels may not be seen below the
33.
34. RADIOGRAPHIC EXAMINATION
• 75 mL-subpulmonic space without spill over, can
obliterate the posterior costophrenic sulcus,
• 175 mL is necessary to obscure the lateral
costophrenic sulcus on an upright chest radiograph
• 500 mL will obscure the diaphragmatic contour on
an upright chest radiograph;
• 1000 ml of effusion reaches the level of the fourth
anterior rib,
• On decubitus radiographs and CT scans, less than 10
mL.
35. RADIOGRAPHIC EXAMINATION
Based on the decubitus films
• small effusions are thinner than 1.5 cm,
moderate effusions are 1.5 to 4.5 cm thick, and
large effusions exceed 4.5 cm.
• Effusions thicker than one cm are usually
large enough for sampling by thoracentesis,
since at least 200 mL of liquid are already
present
36. ROLE OF USG
1.Determining whether pleural fluid is present
2. Identification of appropriate location for an
attempted thoracentesis ,pleural biopsy or chest
tube placement
3. Identification of pleural fluid loculations
4. Distinction of pleural fluid from pleural thickening
5. Quantitation of amount of pleural fluid
6. Differentiation of pyopneumothorax from lung
abscess
7. Assessment as to whether a pleurodesis is present
37. Role of CT scan
• Visualization of underlying lung
parenchymal processes that are obscured on
chest radiographs by large pleural effusions
• Distinguishing empyema from lung abscess
• Help in distinguishing benign from
malignant pleural effusion-pleural nodularity,
mediastinal pleura involvement, pleural
thickening greater than 1 cm.
38.
39. Loculated pleural effusion
• Encapsulated by adhesion anywhere
parietal and visceral pleura or in the interlobar
fissure
• It occurs most commonly with intense pleural
inflammation such as empyema hemothorax,or
tuberculous pleuritis.
• A definitive diagnosis of loculated pleural
effusion is best established by ultrasound
40. Loculated effusion in fissure
1simulate a mass in PA radiograph.
2Most frequently seen in patient with CHF.
3vanishing tumor or pseudotumor.
4the most common location is right horizontal
fissure
41. APPROACH TO THE PATIENT
• If thickness of fluid greater than 10 mm
decubitus radiograph, USG, CT scan, then
we should performing diagnostic
thoracentesis
• In CHF diagnostic thoracentesis is
performed if
1The effusion are not bilateral
2. Patient has pleuritic chest pain
3. Patient is febrile
42.
43. APPEARANCE OF PLEURAL FLUID
• Bloody- Cancer>PE>Trauma>Pneumonia
• Turbid- due to cells or debris or a high lipid level-
Empyema
Chylothorax
pseudochylothorax
• Putrid odour- Anaerobic infection.
• Ammonia odour- urinothorax
44. Bloody : Hematocrit compared to the blood :
• <1% is not significant
• 1-20% indicates either cancer, PE or trauma
• >50% indicates hemothorax.
Centrifuging turbid or milky pleural fluid will distinguish between
empyema and lipid effusions.
• If the supernatant is clear then the turbid fluid was due to
empyema
• If it is still turbid
-chylothorax OR
-pseudochylothorax
- Check TG - >110mg/dl – chylothorax If TG<50mg/dl and
cholesterol>250 - pseudochylothorax
45.
46. PARAPNEUMONIC EFFUSION AND EMPYEMA
• Any pleural effusion associated with bacterial
pneumonia ,lung abscess, or bronchiectasis is a
parapneumonic effusion
• An empyema is pus in pleural space
• Complicated parapneumonic effusion-refer to
those effusion that do not resolve without
therapeutic thoracentesis or tube thoracostomy
47. Bad prognostic factor for parapneumonic effusion
and empyema
1Pus present in pleural space
2. Gram stain of pleural fluid is positive
3. Pleural fluid glucose below 40mg/dl
4. Pleural fluid culture positive
5. Pleural fluid ph<7
6. Pleural fluid LDH >3times upper normal limit for
serum
7. Pleural fluid loculated These factors indicating
likely need for a procedure more invasive than a
48.
49.
50.
51. Pleural effusion related to metastatic malignancies
• 2nd most common cause of exudative pleural
effusion after parapneumonic effusion
• Leading cause of exudative pleural effusion
to thoracentesis
• Common causes of malignant pleural effusion
1.Lung carcinoma
2. Breast carcinoma
3. Lymphoma and leukemia
4. Ovarian carcinoma 5. sarcoma
52. Pleural fluid in malignant pleural effusion
• Almost exudative
• Most pleural effusion that meet exudative criteria by the
LDH but not by protein level are malignant pleural
• bloody pleural effusion
• Low pleural glucose level in malignant pleural effusion
indicates high tumor burden in pleural space
• Approx. one third of patient with malignant disease have
a low PH level. low pleural PH also tend to have a low
pleural glucose level. they have greater tumor burden, are
more likely to have positive pleural fluid cytology and
pleural biopsy.
53. Diagnosis of malignant pleural effusion
• Cytology- is a fast, efficient, and minimally invasive
establishes the diagnosis in more than 70 percent of
of metastatic adenocarcinoma less efficient in the
diagnosis of a mesothelioma squamous cell carcinoma,
lymphoma or a sarcoma.
• Immunohistochemical tests-metastatic adenocarcinoma
tend to stain positive with CEA,MOC31,BG8,TTF1.
malignant mesothelial cells and benign mesothelial cells
stain positive with calretinin,keratin5/6,podoplanin,wt1.
54. • Tumor markers in pleural fluid-CEA,CA,NSE,SCC
antigen, cytokeratin 19 fragment,
• Blood marker of mesothelioma-soluble mesothelin
related protien(smrp),osteopontin,megakaryocye
potentiating factor(MPF)
• If cytology is negative – go for thoracoscopy